Health Economics Expertise

Comprehensive economic analysis to inform healthcare decisions and demonstrate value

Transforming Evidence into Action

We provide rigorous health economic analysis that informs resource allocation, policy development, and investment decisions across diverse healthcare settings.

Core Services

Specialized expertise across the health economics spectrum

01

Cost-Effectiveness Analysis

Comprehensive economic evaluations comparing interventions' costs and health outcomes to identify optimal resource allocation strategies. We conduct CEA following international best practices (CHEERS, ISPOR guidelines) to support reimbursement decisions and policy development.

  • Trial-based and model-based economic evaluation
  • Cost-utility analysis using QALYs and DALYs
  • Incremental cost-effectiveness ratios (ICER)
  • Probabilistic sensitivity analysis
02

Budget Impact Analysis

Financial forecasting to estimate the expected resource implications of adopting new technologies or interventions within specific healthcare systems and time horizons.

  • Multi-year budget projections
  • Epidemiological modeling of eligible populations
  • Market uptake and diffusion scenarios
  • Affordability assessments
03

Economic Burden Studies

Comprehensive assessment of disease-related economic impacts, quantifying direct medical costs, indirect productivity losses, and intangible burden on patients and society.

  • Cost-of-illness studies
  • Healthcare resource utilization analysis
  • Productivity loss valuation
  • Catastrophic health expenditure assessment
04

Health Technology Assessment

Systematic evaluation of clinical effectiveness, economic value, ethical implications, and broader societal impacts of health technologies to support evidence-based coverage decisions.

  • Full HTA dossiers and submissions
  • Systematic literature reviews and meta-analysis
  • Multi-criteria decision analysis
  • Stakeholder consultation and deliberative processes
05

Economic Modeling

Development of sophisticated decision-analytic models, Markov models, discrete event simulations, and system dynamics models to project long-term health and economic outcomes.

  • Decision tree and Markov modeling
  • Discrete event simulation
  • Partitioned survival analysis
  • Model validation and calibration
06

Value-Based Pricing

Evidence-based pricing strategies that align product value with willingness-to-pay thresholds, supporting market access and reimbursement negotiations.

  • Willingness-to-pay assessment
  • Value framework development
  • Risk-sharing arrangements
  • Managed entry agreements

Discover our comprehensive health economics services including cost-effectiveness analysis, budget impact modeling, and health technology assessment.

Need Economic Analysis Support?

Our team is ready to help you demonstrate value and inform evidence-based decisions